Your browser doesn't support javascript.
Early-phase clinical trials in a pandemic: learning from the response to COVID-19.
Horsley, Alex; Brightling, Chris; Davies, Jane; Djukanovic, Ratko; Heaney, Liam G; Hussell, Tracy; Marciniak, Stefan J; McGarvey, Lorcan; Porter, Joanna C; Wilkinson, Thomas; Ho, Ling-Pei.
  • Horsley A; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Brightling C; Leicester NIHR Biomedical Research Centre and Department of Respiratory Sciences, University of Leicester, Leicester, UK.
  • Davies J; Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London UK.
  • Djukanovic R; NIHR Southampton Biomedical Research Centre and School of Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
  • Heaney LG; Wellcome Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK.
  • Hussell T; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
  • Marciniak SJ; Cambridge University Hospitals NHS Foundation Trust, Royal Papworth Hospital NHS Foundation Trust, and University of Cambridge, Cambridge, UK.
  • McGarvey L; Wellcome Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK.
  • Porter JC; UCL Department of Respiratory Medicine, UCL, and UCLH NHS Foundation Trust, London, UK.
  • Wilkinson T; NIHR Southampton Biomedical Research Centre and School of Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
  • Ho LP; Oxford NIHR Biomedical Research Centre and MRC Human Immunology Unit, University of Oxford, Oxford, UK. Electronic address: ling-pei.ho@imm.ox.ac.uk.
Lancet Respir Med ; 10(7): 625-627, 2022 07.
Article in English | MEDLINE | ID: covidwho-2004667
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article Affiliation country: S2213-2600(22)00062-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pandemics / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article Affiliation country: S2213-2600(22)00062-5